Gilead to acquire Myogen for $2.5 billion
471083
Gilead Sciences Inc.  said on Monday it will acquire Myogen Inc.  for $2.5 billion, gaining control of Myogen's experimental heart medicines.
587996
IBM Corp. has offered to buy Telelogic AB, a Swedish developer of software development tools, in a cash deal valued at 5.2 billion Swedish krona, or about US$745 million, the companies announced Monday.
624242
Smiths Group announced the acquisition of Medex, a privately held maker of medical devices. The cost of the deal was reported to be $925 million.
189520
Shares of Mylan Laboratories Inc., the largest US maker of generic drugs, surged Thursday after the company said investor Carl Icahn was given the green light by regulators to buy up to $500 million of the company&#39;s stock.
608996
Generic drug maker Mylan Laboratories Inc.  said on Friday it is raising at least about $993.6 million in a public offering of notes and common shares, with proceeds intended for global operations and potential acquisitions.
351599
NEW YORK -- Johnson &amp; Johnson will acquire Guidant Corp., one of the world&#39;s leading makers of cardiac devices, for about $25.4 billion in cash and stock.
508157
A group led by the investor Carl C. Icahn has agreed to increase its bid for the Lear Corporation, the automotive supplier, by about 3.5 percent, to roughly $2.9 billion.
108565
Danish biotech Genmab A/S on Tuesday signed a deal worth up to $2.1 billion with pharmaceutical company GlaxoSmithKline PLC for the global commercialization of a leukemia treatment.
495128
The maker of cable for communications companies has agreed to buy the Andrew Corporation for about $2.6 billion to bolster sales to mobile phone and wireless Internet companies.
380782
Philips plans to buy U.S. home  medical equipment maker Respironics Inc for $5.1 billion, its  largest deal to date in an aggressive expansion in the  fast-growing healthcare sector.
590969
NEW YORK  - Intelsat Ltd., the world'ssecond-largest satellite operator, said on Monday it agreed tobe bought by a consortium of four private equity firms for $5billion, including assumption of $2 billion of debt.
170831
GlaxoSmithKline Plc  has bought  global rights to Danish biotech company Genmab's  most  promising new drug, a treatment for leukemia, in a record deal  worth up to $2.1 billion, the two firms said on Tuesday.
287707
Serono SA , one of the world's largest biotechnology companies, was bought yesterday by German chemical giant Merck KGaA in a deal worth more than $13 billion.
337666
SAN FRANCISCO -- Billionaire investor Carl C. Icahn was given clearance by US antitrust regulators to purchase shares in Biogen Idec Inc., the world's biggest maker of drugs for multiple sclerosis.
532662
Gilead Sciences Inc. , a leading producer of HIV drugs, said yesterday it plans to acquire biotech firm Myogen Inc. for about $2.5 billion in cash, signaling a surprising expansion into treatments for pulmonary diseases.
654843
Financier Carl Icahn offered Friday to purchase all outstanding shares of Mylan Laboratories Inc. for $20 per share, which would value the company at approximately $5.4 billion, according to The Wall Street Journal.
211571
Shareholders of the company approved a $19.5 billion buyout on Tuesday, more than 10 months after the deal was proposed.